SP
NBIX icon

Symmetry Partners’s Neurocrine Biosciences NBIX Stock Holding History

Symmetry Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,616
Closed -$222K – 359
2024
Q2 		$222K Sell
1,616
-248
-13% -$34.1K 0.01% 477
2024
Q1 		$257K Hold
1,864
– – 0.02% 463
2023
Q4 		$246K Buy
+1,864
New +$246K 0.01% 444